160 related articles for article (PubMed ID: 10739115)
1. Use of membrane vesicles to investigate drug interactions with transporter proteins, P-glycoprotein and multidrug resistance-associated protein.
Wheeler R; Neo SY; Chew J; Hladky SB; Barrand MA
Int J Clin Pharmacol Ther; 2000 Mar; 38(3):122-9. PubMed ID: 10739115
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport.
Loe DW; Almquist KC; Deeley RG; Cole SP
J Biol Chem; 1996 Apr; 271(16):9675-82. PubMed ID: 8621643
[TBL] [Abstract][Full Text] [Related]
3. Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione.
Loe DW; Deeley RG; Cole SP
Cancer Res; 1998 Nov; 58(22):5130-6. PubMed ID: 9823323
[TBL] [Abstract][Full Text] [Related]
4. Cellular and in vitro transport of glutathione conjugates by MRP.
Shen H; Paul S; Breuninger LM; Ciaccio PJ; Laing NM; Helt M; Tew KD; Kruh GD
Biochemistry; 1996 May; 35(18):5719-25. PubMed ID: 8639531
[TBL] [Abstract][Full Text] [Related]
5. ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.
Paul S; Breuninger LM; Tew KD; Shen H; Kruh GD
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6929-34. PubMed ID: 8692921
[TBL] [Abstract][Full Text] [Related]
6. ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing HL60/ADR cells.
Paul S; Breuninger LM; Kruh GD
Biochemistry; 1996 Nov; 35(44):14003-11. PubMed ID: 8909298
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
Draper MP; Martell RL; Levy SB
Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
[TBL] [Abstract][Full Text] [Related]
8. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function.
Chen ZS; Aoki S; Komatsu M; Ueda K; Sumizawa T; Furukawa T; Okumura H; Ren XQ; Belinsky MG; Lee K; Kruh GD; Kobayashi M; Akiyama S
Int J Cancer; 2001 Jul; 93(1):107-13. PubMed ID: 11391629
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells.
Chuman Y; Chen ZS; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Niwa K; Yamada K; Aikou T; Akiyama S
Biochem Biophys Res Commun; 1996 Sep; 226(1):158-65. PubMed ID: 8806607
[TBL] [Abstract][Full Text] [Related]
10. Structure and in vitro substrate specificity of the murine multidrug resistance-associated protein.
Paul S; Belinsky MG; Shen H; Kruh GD
Biochemistry; 1996 Oct; 35(42):13647-55. PubMed ID: 8885844
[TBL] [Abstract][Full Text] [Related]
11. ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene.
Loe DW; Stewart RK; Massey TE; Deeley RG; Cole SP
Mol Pharmacol; 1997 Jun; 51(6):1034-41. PubMed ID: 9187270
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
[TBL] [Abstract][Full Text] [Related]
13. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.
Chuman Y; Chen ZS; Seto K; Sumizawa T; Furukawa T; Tani A; Haraguchi M; Niwa K; Yamada K; Aikou T; Akiyama S
Cancer Lett; 1998 Jul; 129(1):69-76. PubMed ID: 9714337
[TBL] [Abstract][Full Text] [Related]
14. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance.
Gekeler V; Ise W; Sanders KH; Ulrich WR; Beck J
Biochem Biophys Res Commun; 1995 Mar; 208(1):345-52. PubMed ID: 7887949
[TBL] [Abstract][Full Text] [Related]
15. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
Cleary I; Doherty G; Moran E; Clynes M
Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.
Stride BD; Grant CE; Loe DW; Hipfner DR; Cole SP; Deeley RG
Mol Pharmacol; 1997 Sep; 52(3):344-53. PubMed ID: 9281595
[TBL] [Abstract][Full Text] [Related]
17. Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP).
Slapak CA; Martell RL; Terashima M; Levy SB
Biochem Pharmacol; 1996 Nov; 52(10):1569-76. PubMed ID: 8937472
[TBL] [Abstract][Full Text] [Related]
18. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078.
Nagayama S; Chen ZS; Kitazono M; Takebayashi Y; Niwa K; Yamada K; Tani A; Haraguchi M; Sumizawa T; Furukawa T; Aikou T; Akiyama S
Cancer Lett; 1998 Aug; 130(1-2):175-82. PubMed ID: 9751271
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.
Müller M; Meijer C; Zaman GJ; Borst P; Scheper RJ; Mulder NH; de Vries EG; Jansen PL
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):13033-7. PubMed ID: 7809167
[TBL] [Abstract][Full Text] [Related]
20. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.
Renes J; de Vries EG; Nienhuis EF; Jansen PL; Müller M
Br J Pharmacol; 1999 Feb; 126(3):681-8. PubMed ID: 10188979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
